newsfilter
← Latest News
GlobeNewswire·

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB) ("Seres" or the "Company"), a leading live biotherapeutics company, today announced that on September 4,